Novo Nordisk Long-Term Investments 2010-2024 | NVO

Novo Nordisk long-term investments for the quarter ending December 31, 2024 were $0.388B, a 60.75% increase year-over-year.

  • Novo Nordisk long-term investments for 2024 were $0.388B, a 60.75% increase from 2023.
  • Novo Nordisk long-term investments for 2023 were $0.241B, a 26.98% increase from 2022.
  • Novo Nordisk long-term investments for 2022 were $0.19B, a 17.05% decline from 2021.

Novo Nordisk Long-Term Investments 2010-2024 | NVO

  • Novo Nordisk long-term investments for 2024 were $0.388B, a 60.75% increase from 2023.
  • Novo Nordisk long-term investments for 2023 were $0.241B, a 26.98% increase from 2022.
  • Novo Nordisk long-term investments for 2022 were $0.19B, a 17.05% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B